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Abstract
Three series of novel sulfonylurea podophyllotoxin derivatives were designed, synthesized, and
evaluated for in vitro cytotoxicity against four tumor cell lines (A-549, DU-145, KB and KBvin).
Compounds 14c (IC50: 1.41–1.76 μM) and 14e (IC50: 1.72–2.01 μM) showed superior cytotoxic
activity compared with etoposide (IC50: 2.03– >20μM), a clinically available anticancer drug.
Significantly, most of the compounds exhibited comparable cytotoxicity against the drug-resistant
tumor cell line KBvin, while etoposide lost activity completely. Preliminary structure-activity
relationship (SAR) correlations indicated that the 4′-O-methyl functionality in podophyllotoxin
analogues may be essential to maintain cytotoxic activity, while an arylsulfonylurea side chain at
podophyllotoxin’s 4β position can significantly improve cytotoxic activity.
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1. Introduction
Podophyllotoxin (1) is a naturally occurring aryltetralin lignan isolated from various plant
species of the Podophyllum family. It exerts cytotoxic activity by inhibiting microtubule
assembly.1,2 Enormous progress has been achieved concerning the structural elements
required for activity. These findings led to approval of etoposide (3) and teniposide (4), two
semisynthetic glucoside derivatives of 4′-O-demethylepipodophyllotoxin (2), as well as
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etopophos (5), a water-soluble prodrug of 3, as anticancer drugs. Unlike 1, compounds 3–5
exert cytotoxic activity by inhibiting DNA topoisomerase II.3–7
Improved understanding of the mechanism(s) of action, along with extensive structure–
activity and pharmacology studies, reenergized interest in further modification studies on the
C-4 substituent of 2 to increase antitumor activity. Accordingly, various C-4 substituents
were introduced into the parent molecule leading to either enhanced or comparable activity.
Through C4 modification, some nonsugar substituted analogues, particularly N-linked
congeners, were found to exhibit superior pharmacological properties to 3, and several
clinical trial drug candidates, including NPF (6),8 GL-331 (7),9 and TOP-53 (8),10 emerged
as alternatives to overcome the drawbacks of 3. Overall, the excellent activity profiles of
these agents, including improved water solubility, cytotoxic activity, drug resistance
profiles, and antitumor spectra, suggested this compound class could be optimized through
rational C-4 modification. Both a composite pharmacophore model and comparative
molecular field analysis also further demonstrated that the C-4 molecular area could
accommodate considerable structural diversity.11
Based on accumulated SAR studies and critical modeling clues, we have generated focused
libraries of potent aniline, alkylamino, phenol, thiophenol, and carbohydrate derivatives
functionalized at the C-4 position of 2; among which, some compound have exhibited
significant anticancer and DNA topoisomerase II inhibitory activities.2,12 Especially, 4β-
anilino substituted podophyllotoxin derivatives showed potent cytotoxic activity against
some human parental and drug-resistant cancer cell lines.13–19 From these studies, 7 proved
to be more potent than 3 and underwent phase II clinical trials for the treatment of various
cancers. In continuation of these efforts, we recently found that a series of aroylthiourea
derivatives of 4-β-amino-4-desoxypodophyllotoxin displayed potent antitumor activity with
significantly different drug-resistance profiles from those of 1.20 Some new compounds
exhibited promising cytotoxicity against the KBvin drug resistant tumor cell line (e.g., IC50
0.098 and 0.13 μM), while etoposide lost activity completely. In addition, some compounds
were effective in drug-sensitive and drug-resistant xenograft models at lower doses than
etoposide, demonstrating potential as drug candidates for anticancer chemotherapy. These
encouraging results prompted us to further extend our investigation by synthesizing a novel
series of sulfonylurea podophyllotoxin derivatives. The sulfonylurea group was chosen
based on the facts that this group is commonly found in various drugs and introduction of a
bioactive sulfonylurea group can usually potentiate the biochemical or pharmacological
properties of the original molecule.21 Therefore, in this paper, we describe our introduction
of sulfonylurea groups into the podophyllotoxin skeleton via a coupling reaction and our
cytotoxic activity studies on the resulting compounds.
2. Results and discussion
2.1. Chemistry
The synthetic routes to target podophyllotoxin derivatives are outlined in Schemes 1 and 2.
Briefly, precursor 4-azidopodophyllotoxins 9 and 10 were prepared from 1 and 2 by
employing the BF3-Et2O/HN3 reagent system. Both 9 and 10 were then reduced under
hydrogen atmosphere with Pd/C catalyst to yield the key intermediate 4β-amino congeners
11 and 12, respectively, in excellent yields.22 Next, intermediates 11 and 12 were coupled
with various sulfonylcarbamates in dry toluene to afford the desired 4β-sulfonylurea
podophyllotoxins 13a–l and 14a–e, respectively, in good yields.
As illustrated in Scheme 2, initially, silyl-protected podophyllotoxin 15 was produced in
excellent yield following a classical synthetic method with tert-butyldimethylsilyl chloride
(TBDMSCl) and imidazole in DMF. Furthermore, another key precursor
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anhydropodophyllotoxin (18) was synthesized by the following sequence, reduction of 15
with lithium aluminum hydride (LiAlH4), followed by closure of the resulting diol 16 to
cyclic ether 17 with a mixture of triphenylphosphine (TPP) and diethyl azodicarboxylate
(DEAD), and subsequently, deprotection with tetrabutylammonium fluoride (Bu4NF).23
Similarly, intermediate 4β-amino-anhydropodophyllotoxin (20) was prepared from 18
through azidation and catalytic hydrogenation via a similar procedure to that described
above for 11 and 12. Finally, using similar methods to those for 13a–l and 14a–e, target
compounds 21a–c were obtained from 20 in yields ranging from 67% to 82%. All newly
synthesized compounds were purified by column chromatography and their structures were
confirmed by 1H-NMR, 13C-NMR, and ESI-MS data.
2.2. Cytotoxicity and SAR
Target compounds 13a–l, 14a–e and 21a–c were evaluated for in vitro cytotoxicity against
four human tumor cell lines, A549 (non-small cell lung cancer), DU145 (prostate cancer),
KB (nasopharyngeal carcinoma), and KBvin [multi-drug resistant (MDR) KB subline
selected using vincristine], using a sulforhodamine B colorimetric (SRB) assay with
triplicate experiments.24 Compound 3 was included as positive control and the results are
summarized in Table 1.
Notably, compounds 14c and 14e showed superior activity (IC50 1.41–1.76 and 1.72–2.01
μM, respectively) compared with 3 (IC50 2.03–3.88 μM) against A549, DU-145, and KB
tumor cell lines. Most importantly, these two compounds retained significant cytotoxicity
(IC50 1.76 and 2.01 μM, respectively) against the drug resistant KBvin tumor cell line, while
3 lost its activity completely (IC50 > 20 μM). This result is in agreement with our prior
observation that C4-amino substitution of 2 is favorable for overcoming drug-resistance.25
Although 4′-O-methylated derivatives 14c and 14e showed significant cytotoxicity, their
corresponding 4′-hydroxyl analogues 13d and 13i displayed only marginal activity (IC50
8.10–8.76 and 7.95–11.52 μM, respectively). Similar results were seen in our previous
study,20 and highlight the critical role of the 4′-O-methyl functionality in sulfonylurea-
substituted 2-derivatives.
4′-O-Methylated derivatives 14a, 14b, and 14c with methyl, ethyl, and 4-methylphenyl
groups on the sulfonylurea side chain were obviously much less potent (IC50 >20 μM) than
14c and 14e with phenyl and 4-chlorophenyl groups in the R2 position. These results were
unexpected,26 and further investigation is needed.
Within the 4′-O-demethylated series (13a–l), compounds 13a and 13b with methyl- and
ethyl-sulfonylurea groups, respectively, were inactive (IC50 > 20 μM), while 13c with a
butyl R2 group showed marginal to weak cytotoxicity (IC50 7.96–13.95 μM), indicating that
the substituent’s size is critical. Except for 13f, 4′-O-demethylated compounds with
phenylsulfonylurea groups (13c–13e, 13g–13k) showed similar potency (IC50 7.67–13.99
μM) to 13c against all tested tumor cell lines. Cytotoxic potency was only slightly affected
by the electronegativity or positions of substituents on the phenyl ring. Moreover, compound
13l with a 2-naphthylsulfonylurea group showed comparable potency to compounds with a
phenyl group.
Subsequently, to investigate whether the lactone moiety can influence cytotoxic activity, 4β-
sulfonylurea anhydropodophyllotoxin compounds 21a–c were prepared. As shown in Table
1, compound 21a was inactive, while 21b and 21c were less potent than the related lactone
compounds 13g and 13k, suggesting that the lactone moiety might be important for
antitumor effects. However, further investigation is warranted including comparison with 4′-
O-methylated lactone compounds.
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In summary, three series of novel 4β-sulfonylurea podophyllotoxin derivatives were
designed, synthesized, and evaluated for cytotoxicity against four tumor cell lines (A-549,
DU-145, KB and KBvin) by using a sulforhodamine B colorimetric assay. Among them,
compounds 14c and 14e were the most promising derivatives with greater potency than 3
and were selected as lead molecules for further development. The cytotoxic results revealed
that the 4′-O-methyl functionality was essential in increasing cytotoxicity in the 1-derived
compounds, and aryl substituents on the sulfonylurea moiety were advantageous. These
findings support our further optimization of 1 to develop potential anticancer drug
candidates. Continuing studies to substantiate and improve activity profiles are underway in
our laboratory and will be reported in due course.
4. Experimental section
4.1. Chemistry
Melting points were taken on a Kofler melting point apparatus and are uncorrected. Mass
spectra were recorded on a Bruker Daltonics APEXII49e spectrometer with ESI source as
ionization. 1H and 13C NMR spectra were recorded at 400 MHz and 100 MHz on a Bruker
AM-400 spectrometer using TMS as reference (Bruker Company, USA). Optical rotations
were measured on an Autopol IV polarimeter (Rudolph, USA) in a 10 mm cell at 21 °C.
Podophyllotoxin (1) was isolated from the Chinese medicinal herb Juniperus sabina
Linnaeus, and served as the starting material for preparation of all new derivatives. The
starting sulfonylcarbamates were prepared according to the procedure reported
previously.27,28 The key intermediate 4β-amino congeners 11, 12 and 20 were synthesized
by our previously reported procedures, and their structures confirmed by direct comparison
with an authentic sample and previously reported spectroscopic data.21,22
4.2. General synthetic procedure for target compounds 13a–l, 14a–e and 21a–c
Key intermediates 11, 12 and 20 (0.2 mmol) were added dropwise to a solution of 0.4 mmol
of sulfonylcarbamate in dry toluene (20 mL). The reaction mixture was refluxed for 2~4 h
and then concentrated. The residue was purified by chromatography on silica gel using
CHCl3/MeOH as eluant to give 13a–l, 14a–e, and 21a–c, which were stable both at
chemical purification stage and under assay conditions.
4.2.1. 4β-N-(Methylsulfonylurea)-4-deoxy-4′-demethylepipodophyllotoxin (13a)
—Yield: 50%; mp: 180–182 °C;  −31.4° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 8.29 (s, 1H, -CONHSO2-), 6.87 (s, 1H, 5-H), 6.53 (s, 1H, 8-H), 6.21 (s, 2H, 2′, 6′-H),
6.00 and 5.98 (ABq, 2H, -OCH2O-), 5.01-4.98 (m, 1H, 4-H), 4.49 (d, 1H, 1-H, J=5.2 Hz),
4.32 (t, 1H, 11β-H, J=8 Hz), 3.81 (t, 1H, 11α-H, J=9.2 Hz), 3.61 (s, 6H, 3′, 5′-OCH3), 3.25
(s, 3H, 1″-H), 3.10 (dd, 1H, 2-H, J=14.4, 5.2 Hz), 2.98–2.91 (m, 1H, 3-H); 13C NMR (100
MHz, DMSO-d6) δ: 174.7, 152.4, 147.6, 147.3, 146.8, 137.4, 134.8, 132.6, 130.2, 129.8,
128.4, 119.8, 109.5, 108.5, 101.5, 56.2, 42.9, 41.6, 40.8; ESI-MS: m/z 521.0 [M+H]+.
4.2.2. 4β-N-(Ethylsulfonylurea)-4-deoxy-4′-demethylepipodophyllotoxin (13b)
—Yield: 52%; mp: 160–162 °C;  −77.6° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 8.29 (s, 1H, -CONHSO2-), 6.86 (s, 1H, 5-H), 6.53 (s, 1H, 8-H), 6.21 (s, 2H, 2′, 6′-H),
6.00 and 5.98 (ABq, 2H, -OCH2O-), 5.01-4.98 (m, 1H, 4-H), 4.49 (d, 1H, 1-H, J=5.2 Hz),
4.32 (t, 1H, 11β-H, J=8 Hz), 3.78 (t, 2H, 1″-H, J=10.4 Hz), 3.61 (s, 6H, 3′, 5′-OCH3), 3.15
(dd, 1H, 2-H, J=14.4, 5.2 Hz), 2.98-2.91 (m, 1H, 3-H), 1.25-1.16 (m, 3H, 2″-H); 13C NMR
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(100 MHz, DMSO-d6) δ: 174.6, 152.3, 147.6, 147.3, 146.8, 134.8, 132.6, 130.2, 129.8,
109.7, 109.3, 108.5, 101.5, 56.2, 47.3, 42.9, 40.8, 37.0; ESI-MS: m/z 535.0 [M+H]+.
4.2.3. 4β-N-(Butylsulfonylurea)-4-deoxy-4′-demethylepipodophyllotoxin (13c)
—Yield: 49%; mp: 161–163 °C;  −85.4° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 8.28 (s, 1H, -CONHSO2-), 6.84 (s, 1H, 5-H), 6.47 (s, 1H, 8-H), 6.20 (s, 2H, 2′, 6′-H),
5.98 and 5.96 (ABq, 2H, -OCH2O-), 5.03-5.02 (m, 1H, 4-H), 4.43 (d, 1H, 1-H, J=4.8 Hz),
4.29 (t, 1H, 11β-H, J=8 Hz), 4.03-4.00 (m, 1H, 11α-H), 3.60 (s, 6H, 3′, 5′-OCH3), 3.15-3.07
(m, 1H, 2-H), 2.97 (t, 2H, 1″-H, J=7.6 Hz), 2.94-2.84 (m, 1H, 3-H), 1.58-1.56 (m, 2H, 2″-
H), 1.38-1.32 (m, 2H, 3″-H), 1.16 (t, 3H, 4″-H, J=6.8 Hz); 13C NMR (100 MHz, DMSO-d6)
δ: 147.3, 136.0, 134.8, 108.5, 105.3, 56.1, 43.1, 30.9, 21.3, 13.9; ESI-MS: m/z 585.1 [M
+Na]+.
4.2.4. 4β-N-(Phenylsulfonylurea)-4-deoxy-4′-demethylepipodophyllotoxin (13d)
—Yield: 59%; mp: 195–197 °C;  −33.8° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 8.27 (s, 1H, -CONHSO2-), 7.92 (d, 2H, 2″, 6″-H, J=7.6 Hz), 7.69 (t, 1H, 4″-H, J=7.6
Hz), 7.61 (t, 2H, 3″, 5″-H, J=7.6 Hz), 6.71 (s, 1H, 5-H), 6.51 (s, 1H, 8-H), 6.18 (s, 2H, 2′, 6′-
H), 5.99 and 5.97 (ABq, 2H, -OCH2O-), 4.90-4.87 (m, 1H, 4-H), 4.46 (d, 1H, 1-H, J=5.2
Hz), 4.13 (t, 1H, 11α-H, J=8 Hz), 3.59 (s, 6H, 3′, 5′-OCH3), 3.10 (dd, 1H, 2-H, J=14.4, 5.2
Hz), 2.88-2.78 (m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ: 174.4, 167.1, 151.6, 147.4,
147.2, 146.7, 140.3, 134.7, 133.3, 132.5, 130.1, 129.6, 129.1, 127.3, 109.5, 109.1, 108.4,
101.4, 68.1, 56.0, 47.8, 42.8, 40.7, 36.7; ESI-MS: m/z 583.3 [M+H]+.
4.2.5. 4β-N-(4″-Methoxyphenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13e)—Yield: 42%; mp: 166–168 °C;  −59.4° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 9.03 (s, 1H, -CONHSO2-), 7.84 (d, 2H, 2″, 6″-
H, J=8.8 Hz), 7.76 (d, 2H, 3″, 5″-H, J=8.8 Hz), 6.77 (s, 1H, 5-H), 6.51 (s, 1H, 8-H), 6.20 (s,
2H, 2′, 6′-H), 6.02 and 6.01 (ABq, 2H, -OCH2O-), 5.00-4.97 (m, 1H, 4-H), 4.50 (d, 1H, 1-H,
J=4.8 Hz), 4.46-4.41 (m, 2H, 11-H), 3.84 (s, 3H, 4″-OCH3), 3.62 (s, 6H, 3′, 5′-OCH3), 3.16
(dd, 1H, 2-H, J=14, 4.8 Hz), 2.96-2.82 (m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ:
174.0, 162.2, 147.7, 147.3, 146.9, 134.9, 132.3, 129.9, 129.6, 114.3, 109.6, 108.6, 56.1,
42.8, 40.7, 38.0, 30.8; ESI-MS: m/z 630.5 [M+NH4]+.
4.2.6. 4β-N-(4″-Methylphenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13f)—Yield: 56%; mp: 193–195 °C;  −50.0° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 8.29 (br s, 1H, -CONHSO2-), 7.87-7.71 (m, 2H,
2″, 6″-H), 7.23-7.18 (m, 2H, 3″, 5″-H), 6.78 (s, 1H, 5-H), 6.51 (s, 1H, 8-H), 6.20 (s, 2H, 2′,
6′-H), 5.97 and 5.96 (ABq, 2H, -OCH2O-), 4.93-4.92 (m, 1H, 4-H), 4.42 (d, 1H, 1-H, J=5.2
Hz), 4.12 (br s, 2H, 11-H, J=8 Hz), 3.59 (s, 6H, 3′, 5′-OCH3), 3.15 (m, 1H, 2-H), 2.79 (m,
1H, 3-H), 2.336 (s, 3H, 4″-CH3); 13C NMR (100 MHz, DMSO-d6) δ: 174.8, 172.5, 147.3,
146.7, 134.8, 132.2, 131.0, 130.4, 129.0, 126.9, 109.5, 109.2, 108.5, 101.4, 68.5, 63.0, 56.2,
48.8, 47.6, 43.0, 40.9, 37.0, 30.9, 21.4; ESI-MS: m/z 597.0 [M+H]+.
4.2.7. 4β-N-(4″-Isopropylphenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13g)—Yield: 41%; mp: 172–174 °C;  −53.1° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 9.04 (s, 1H, -CONHSO2-), 7.84 (d, 2H, 2″, 6″-
H, J=8 Hz), 7.75 (d, 2H, 3″, 5″-H, J=8 Hz), 6.79 (s, 1H, 5-H), 6.51 (s, 1H, 8-H), 6.21 (s, 2H,
2′, 6′-H), 5.98 and 5.97 (ABq, 2H, -OCH2O-), 5.01-4.98 (m, 1H, 4-H), 4.51 (d, 1H, 1-H,
J=4.8 Hz), 4.44-4.41 (m, 2H, 11-H), 3.64 (s, 6H, 3′, 5′-OCH3), 3.17 (dd, 1H, 2-H, J=14.4,
4.8 Hz), 3.01-2.91 (m, 1H, 3-H), 2.88-2.83 (m, 1H, 7″-H), 1.22-1.18 (m, 6H, 7″-CH3); 13C
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NMR (100 MHz, DMSO-d6) δ: 174.4, 172.2, 166.7, 164.8, 153.8, 147.7, 147.3, 146.7,
134.8, 132.3, 130.1, 129.9, 129.4, 127.1, 126.9, 109.6, 109.4, 108.6, 101.4, 84.7, 56.2, 50.6,
42.7, 40.7, 37.5, 30.8, 23.6; ESI-MS: m/z 624.3 [M]+.
4.2.8. 4β-N-(4″-Fluorophenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13h)—Yield: 38%; mp: 167–169 °C;  −94.7° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 9.03 (s, 1H, -CONHSO2-), 7.71 (d, 2H, 2″, 6″-
H, J=8 Hz), 7.28 (d, 2H, 3″, 5″-H, J=8 Hz), 6.99 (br s, 1H, 4-NH), 6.71 (s, 1H, 5-H), 6.46 (s,
1H, 8-H), 6.18 (s, 2H, 2′, 6′-H), 6.01 and 5.98 (ABq, 2H, -OCH2O-), 5.00-4.97 (m, 1H, 4-
H), 4.43 (d, 1H, 1-H, J=7.2 Hz), 4.03-4.01 (m, 1H, 11β-H), 3.89-3.87 (m, 1H, 11α-H), 3.62
(s, 6H, 3′, 5′-OCH3), 3.15-3.13 (m, 1H, 2-H), 2.93-2.86 (m, 1H, 3-H); 13C NMR (100 MHz,
DMSO-d6) δ: 174.5, 151.5, 147.7, 147.3, 146.9, 141.7, 137.3, 134.9, 132.2, 130.8, 129.9,
129.6, 116.5, 114.7, 109.6, 108.6, 101.5, 67.8, 56.2, 50.4, 44.4, 42.8, 40.7, 37.5; ESI-MS: m/
z 601.0 [M+H]+.
4.2.9. 4β-N-(4″-Chlorophenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13i)—Yield 35%; mp: 162–164 °C;  −50.8° (c 0.5, CHCl3); 1H
NMR (400 MHz, DMSO-d6) δ: 9.02 (s, 1H, -CONHSO2-), 8.36 (d, 2H, 2″, 6″-H, J=8.8 Hz),
7.64 (d, 2H, 3″, 5″-H, J=7.6 Hz), 6.78 (s, 1H, 5-H), 6.62 (s, 1H, 8-H), 6.18 (s, 2H, 2′, 6′-H),
6.00 and 5.98 (ABq, 2H, -OCH2O-), 4.91-4.87 (m, 1H, 4-H), 4.70 (d, 1H, 1-H, J=5.2 Hz),
4.17 (t, 1H, 11α-H, J=7.6 Hz), 3.60 (s, 6H, 3′, 5′-OCH3), 3.17-3.12 (m, 1H, 2-H), 2.88-2.87
(m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ: 174.5, 147.3, 140.9, 129.4, 129.2, 126.9,
108.5, 106.5, 101.4, 56.1, 55.4, 30.8; ESI-MS: m/z 640.4 [M+Na]+.
4.2.10. 4β-N-(Benzylsulfonylurea)-4-deoxy-4′-demethyl-epipodophyllotoxin
(13j)—Yield: 50%; mp: 158–160 °C;  −31.0° (c 0.5, CHCl3); 1H NMR (400 MHz,
DMSO-d6) δ: 8.33 (s, 1H, -CONHSO2-), 7.40 (s, 5H, Ar-H), 6.91 (br s, 1H, 4-NH), 6.85 (s,
1H, 5-H), 6.54 (s, 1H, 8-H), 6.23 (s, 2H, 2′, 6′-H), 6.04 and 6.01 (ABq, 2H, -OCH2O-),
5.09-5.08 (m, 1H, 4-H), 4.49 (d, 1H, 1-H, J=4.8 Hz), 4.39 (t, 1H, 11β-H, J=8 Hz), 3.79 (t,
1H, 11α-H, J=10 Hz), 3.63 (s, 6H, 3′, 5′-OCH3), 3.17(s, 2H, -SO2CH2-), 3.10 (dd, 1H, 2-H,
J=14.4, 4.8 Hz), 2.98-2.95 (m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ: 174.5, 152.4,
147.5, 147.3, 146.8, 134.8, 132.5, 130.9, 130.1, 129.9, 129.7, 128.7, 127.3, 109.6, 109.1,
108.5, 101.5, 68.4, 58.1, 56.1, 47.9, 42.9, 40.8, 36.8, 30.8; ESI-MS: m/z 596.5 [M]+.
4.2.11. 4β-N-(2″,4″-Dimethoxyphenylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13k)—Yield: 42%; mp: 166–168 °C;  −21.0° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 8.28 (s, 1H, -CONHSO2-), 7.74 (d, 1H, 6″-H,
J=8.8 Hz), 6.86 (d, 1H, 4-NH, J=8 Hz), 6.73 (d, 1H, 3″-H, J=2 Hz), 6.71 (s, 1H, 5-H), 6.65
(dd, 1H, 5″-H, J=8.8, 2 Hz), 6.53 (s, 1H, 8-H), 6.19 (s, 2H, 2′, 6′-H), 6.02 and 6.01 (ABq,
2H, -OCH2O-), 4.89-4.86 (m, 1H, 4-H), 4.51 (d, 1H, 1-H, J=5.2 Hz), 4.11 (t, 1H, 11α-H,
J=8 Hz), 3.85 (s, 6H, 2″, 4″-OCH3), 3.60 (s, 6H, 3′, 5′-OCH3), 2.94 (dd, 1H, 2-H, J=14.4,
5.2 Hz), 2.88-2.79 (m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ: 174.3, 165.1, 158.0,
151.5, 147.5, 147.2, 146.8, 134.8, 132.5, 130.0, 129.6, 119.0, 109.6, 109.0, 108.5, 105.1,
101.5, 99.3, 68.1, 56.5, 56.1, 47.6, 42.9, 40.8, 36.7, 30.8; ESI-MS: m/z 665.1 [M+Na]+.
4.2.12. 4β-N-(2″-Naphthylsulfonylurea)-4-deoxy-4′-demethyl-
epipodophyllotoxin (13l)—Yield: 47%; mp: 176–178 °C;  −16.3° (c 0.5,
CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 8.43 (s, 1H, -CONHSO2-), 8.31 (s, 1H, 3″-H),
8.23 (d, 2H, 1″, 4″-H, J=8 Hz), 8.08-8.02 (m, 4H, 5″, 6″, 7″, 8″-H), 6.83 (s, 1H, 5-H), 6.50
(s, 1H, 8-H), 6.23 (s, 2H, 2′, 6′-H), 6.00 and 5.98 (ABq, 2H, -OCH2O-), 4.99-4.96 (m, 1H,
Zhang et al. Page 6













4-H), 4.46 (d, 1H, 1-H, J=4.8 Hz), 4.33 (t, 1H, 11β-H, J=8.4 Hz), 3.80 (t, 1H, 11α-H, J=10.8
Hz), 3.62 (s, 6H, 3′, 5′-OCH3), 3.29 (dd, 1H, 2-H, J=14.4, 5.2 Hz), 2.99-2.90 (m, 1H, 3-
H); 13C NMR (100 MHz, DMSO-d6) δ: 174.7, 172.2, 170.1, 166.0, 156.4, 147.3, 146.6,
141.3, 140.3, 136.3, 134.8, 132.1, 131.8, 129.6, 129.4, 129.2, 128.5, 127.9, 127.6, 122.6,
109.5, 109.1, 108.5, 101.3, 68.2, 60.2, 56.1, 48.7, 43.0, 40.7, 36.6; ESI-MS: m/z 671.0 [M
+K]+.
4.2.13. 4β-N-(Methylsulfonylurea)-4-deoxyepipodophyllotoxin (14a)—Yield:
54%; mp: 192–194 °C;  −33.3° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 6.88
(s, 1H, 5-H), 6.53 (s, 1H, 8-H), 6.26 (s, 2H, 2′, 6′-H), 6.00 and 5.99 (ABq, 2H, -OCH2O-),
5.01 (dd, 1H, 4-H, J=7.6, 4.4 Hz), 4.54 (d, 1H, 1-H, J=5.2 Hz), 4.34 (t, 1H, 11β-H, J=8 Hz),
3.85-3.80 (m, 1H, 11α-H), 3.63 (s, 6H, 3′, 5′-OCH3), 3.60 (s, 3H, 4′-OCH3), 3.22 (s, 3H, 1″-
H), 3.19-3.17 (m, 1H, 2-H), 3.05-2.89 (m, 1H, 3-H); 13C NMR (100 MHz, DMSO-d6) δ:
174.6, 152.2, 147.6, 146.9, 136.5, 135.9, 132.2, 130.0, 109.6, 109.4, 108.2, 101.5, 68.6,
60.1, 55.9, 47.9, 43.2, 41.5, 40.7, 37.1, 30.9; ESI-MS: m/z 535.0 [M+H]+.
4.2.14. 4β-N-(Ethylsulfonylurea)-4-deoxyepipodophyllotoxin (14b)—Yield: 57%;
mp: 163–165 °C;  −85.7° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 6.87 (s,
1H, 5-H), 6.54 (s, 1H, 8-H), 6.26 (s, 2H, 2′, 6′-H), 6.00 and 5.99 (ABq, 2H, -OCH2O-), 5.01
(dd, 1H, 4-H, J=8, 4.8 Hz), 4.54 (d, 1H, 1-H, J=5.2 Hz), 4.34 (t, 1H, 11β-H, J=8 Hz), 3.79
(t, 1H, 11α-H, J=10.4 Hz), 3.63 (s, 6H, 3′, 5′-OCH3), 3.60 (s, 3H, 4′-OCH3), 3.20 (dd, 1H,
2-H, J=14.4, 5.2 Hz), 2.99-2.89 (m, 1H, 3-H), 1.23 (t, 3H, 2″-H, J=7.6 Hz); 13C NMR (100
MHz, DMSO-d6) δ: 174.5, 152.3, 147.6, 146.9, 136.4, 135.9, 132.2, 129.8, 116.8, 109.6,
109.3, 108.2, 101.5, 97.5, 68.5, 64.1, 60.1, 55.9, 52.7, 47.2, 43.1, 40.6, 8.1; ESI-MS: m/z
549.0 [M+H]+.
4.2.15. 4β-N-(Phenylsulfonylurea)-4-deoxyepipodophyllotoxin (14c)—Yield:
54%; mp: 158–160 °C;  −34.8° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 7.91
(d, 2H, 2″, 6″-H, J=7.6 Hz), 7.66-7.54 (m, 3H, 3″, 4″, 5″-H), 6.93 (br s, 1H, 4-NH), 6.73 (s,
1H, 5-H), 6.51 (s, 1H, 8-H), 6.24 (s, 2H, 2′, 6′-H), 6.01 and 5.99 (ABq, 2H, -OCH2O-),
5.01-4.98 (m, 1H, 4-H), 4.51 (d, 1H, 1-H, J=5.2 Hz), 4.17-4.13 (m, 1H, 11α-H), 3.65-3.60
(s, 9H, 3′, 4′, 5′-OCH3), 3.21 (dd, 1H, 2-H, J=14, 5.2 Hz), 2.96-2.87 (m, 1H, 3-H); 13C
NMR (100 MHz, DMSO-d6) δ: 173.9, 166.7, 152.1, 147.7, 147.0, 140.7, 136.5, 135.8,
133.2, 133.0, 130.8, 129.6, 129.2, 127.5, 109.7, 108.2, 101.5, 60.0, 55.9, 50.6, 42.9, 40.5,
37.7; ESI-MS: m/z 596.5 [M]+.
4.2.16. 4β-N-(4″-Methylphenylsulfonylurea)-4-deoxyepipodophyllotoxin (14d)
—Yield: 49%; mp: 197–198 °C;  −57.5° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 7.81 (d, 2H, 2″, 6″-H, J=8.4 Hz), 7.41 (d, 2H, 3″, 5″-H, J=8 Hz), 6.71 (s, 1H, 5-H),
6.52 (s, 1H, 8-H), 6.22 (s, 2H, 2′, 6′-H), 5.99 (ABq, 2H, -OCH2O-), 4.89 (dd, 1H, 4-H, J=8,
4.8 Hz), 4.51 (d, 1H, 1-H, J=5.6 Hz), 4.15 (t, 1H, 11β-H, J=8 Hz), 4.01-3.95 (m, 1H, 11α-
H), 3.61 (s, 6H, 3′, 5′-OCH3), 3.59 (s, 3H, 4′-OCH3), 3.15-3.10 (m, 1H, 2-H), 2.89-2.79 (m,
1H, 3-H), 2.39 (s, 3H, 4″-CH3); 13C NMR (100 MHz, DMSO-d6) δ: 174.4, 152.1, 147.4,
146.8, 136.4, 135.8, 132.0, 129.3, 127.3, 109.5, 109.2, 108.2, 101.5, 68.3, 60.0, 55.9, 47.7,
43.1, 40.5, 36.9, 30.9, 21.2; ESI-MS: m/z 649.3 [M+K]+.
4.2.17. 4β-N-(4″-Chlorophenylsulfonylurea)-4-deoxyepipodophyllotoxin (14e)
—Yield: 42%; mp: 160–162 °C;  −45.1° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-
d6) δ: 7.93 (d, 2H, 2″, 6″-H, J=8.4 Hz), 7.69 (d, 2H, 3″, 5″-H, J=8.8 Hz), 6.73 (s, 1H, 5-H),
6.52 (s, 1H, 8-H), 6.23 (s, 2H, 2′, 6′-H), 5.99 and 5.98 (ABq, 2H, -OCH2O-), 4.90 (dd, 1H,
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4-H, J=7.6, 4.4 Hz), 4.51 (d, 1H, 1-H, J=5.2 Hz), 4.18 (t, 1H, 11α-H, J=8.4 Hz), 3.61 (s, 6H,
3′, 5′-OCH3), 3.59 (s, 3H, 4′-OCH3), 3.17 (dd, 1H, 2-H, J=14.4, 5.6 Hz), 2.92-2.81 (m, 1H,
3-H); 13C NMR (100 MHz, DMSO-d6) δ: 174.4, 152.1, 147.5, 146.8, 136.5, 135.8, 132.1,
129.8, 129.4, 129.3, 108.2, 101.5, 61.6, 60.1, 55.9, 49.8, 47.8, 43.1, 36.8; ESI-MS: m/z
631.5 [M+H]+.
4.2.18. 4β-N-(Methylsulfonylurea)-4-deoxyanhydroepipodophyllotoxin (21a)—
Yield: 47%; mp: 153–155 °C;  −51.1° (c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6)
δ: 6.88 (d, 1H, 4-NH, J=8.4 Hz), 6.83 (s, 1H, 5-H), 6.45 (s, 1H, 8-H), 6.14 (s, 2H, 2′, 6′-H),
5.99 and 5.97 (ABq, 2H, -OCH2O-), 5.00 (dd, 1H, 4-H, J=8, 3.6 Hz), 4.34 (d, 1H, 1-H,
J=5.2 Hz), 4.04-3.99 (m, 2H, 11-H), 3.92 (t, 1H, 12β-H, J=7.6 Hz), 3.79 (t, 1H, 12α-H,
J=7.6 Hz), 3.64 (s, 6H, 3′, 5′-OCH3), 3.61 (s, 3H, 4′-OCH3), 2.77-2.73 (m, 1H, 3-H),
2.42-2.40 (m, 1H, 2-H), 1.98 (s, 3H, 1″-CH3); 13C NMR (100 MHz, DMSO-d6) δ: 170.4,
152.4, 152.0, 147.2, 146.4, 136.7, 136.1, 132.5, 130.6, 109.5, 109.1, 108.9, 107.3, 107.1,
101.2, 69.0, 67.5, 67.4, 60.0, 59.9, 59.8, 55.9, 47.0, 46.9, 44.7, 44.6, 41.4, 41.3, 38.6, 20.8,
14.2; ESI-MS: m/z 543.0 [M+Na]+.
4.2.19. 4β-N-(4″-Isopropylphenylsulfonylurea)-4-
deoxyanhydroepipodophyllotoxin (21b)—yield 48.8%; mp: 197–199 °C;  −76.5°
(c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 7.81 (d, 2H, 2″, 6″-H, J=8 Hz), 7.48 (d,
2H, 3″, 5″-H, J=8 Hz), 6.80 (d, 1H, 4-NH, J=8.4 Hz), 6.65 (s, 1H, 5-H), 6.43 (s, 1H, 8-H),
6.11 (s, 2H, 2′, 6′-H), 5.97 and 5.96 (ABq, 2H, -OCH2O-), 4.88-4.87 (m, 1H, 4-H), 4.31 (d,
1H, 1-H, J=3.6 Hz), 3.88-3.87 (m, 2H, 11-H), 3.62 (s, 6H, 3′, 5′-OCH3), 3.59 (s, 3H, 4′-
OCH3), 3.00-2.98 (m, 2H, 12-H), 2.72-2.68 (m, 1H, 3-H), 2.34 (m, 2H, 2-H, 7″-H), 1.21 (d,
6H, 7″-CH3, J=6.8 Hz); 13C NMR (100 MHz, DMSO-d6) δ: 154.7, 152.8, 151.6, 147.7,
146.8, 137.8, 137.1, 136.6, 132.9, 130.9, 127.8, 127.4, 109.9, 109.2, 107.7, 101.6, 69.3,
67.7, 60.4, 56.3, 47.3, 45.0, 38.9, 33.9, 23.9; ESI-MS: m/z 624.7 [M]+.
4.2.20.4β-N-(2″,4″-Dimethoxyphenylsulfonylurea)-4-
deoxyanhydroepipodophyll otoxin (21c)—Yield: 45%; mp: 152–154 °C;  −40.4°
(c 0.5, CHCl3); 1H NMR (400 MHz, DMSO-d6) δ: 7.69 (d, 1H, 6″-H, J=8.8 Hz), 6.74-6.62
(m, 4H, 4-NH, 5-H, 3″-H, 5″-H), 6.44 (s, 1H, 8-H), 6.11 (s, 2H, 2′, 6′-H), 5.98 (ABq, 2H, -
OCH2O-), 4.84 (dd, 1H, 4-H, J=8.4, 4 Hz), 4.33 (d, 1H, 1-H, J=5.6 Hz), 3.91-3.88 (m, 2H,
11-H), 3.84 (s, 3H, 2″-OCH3), 3.81 (s, 3H, 4″-OCH3), 3.62 (s, 6H, 3′, 5′-OCH3), 3.59 (s,
3H, 4′-OCH3), 2.98 (t, 1H, 12β-H, J=8.4 Hz), 2.71 (t, 1H, 12α-H, J=8.8 Hz), 2.37-2.27 (m,
2H, 3, 2-H); 13C NMR (100 MHz, DMSO-d6) δ: 172.1, 164.8, 157.8, 152.4, 152.3, 151.3,
147.2, 146.5, 136.7, 136.1, 132.3, 130.8, 119.1, 109.5, 109.4, 108.8, 107.3, 107.1, 105.0,
101.2, 101.0, 99.2, 68.9, 67.1, 59.9, 56.3, 46.7, 44.6, 40.0, 38.4, 21.1; ESI-MS: m/z 643.1 [M
+H]+.
4.3. Antiproliferative activity assay
Antiproliferative activity was determined by the sulforhodamine B (SRB) colorimetric assay
as previously described.27 In brief, the cells (3–5 × 103 cells/well) were seeded in 96-well
plates filled with RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS)
containing various concentrations of samples, and incubated for 72 h. At the end of the
exposure period, the attached cells were fixed with cold 50% trichloroacetic acid for 30 min
followed by staining with 0.04% SRB (Sigma Chemical Co.) for 30 min. The bound SRB
was solubilized in 10 mM Tris-base and the absorbance was measured at 515 nm on a
Microplate Reader ELx800 (Bio-Tek Instruments, Winooski, VT) with a Gen5 software. All
results were representative of three or more experiments.
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Structures of podophyllotoxin derivatives.
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Synthesis of 4β-sulfonylurea podophyllotoxin congeners 13a–l and 14a–e.
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Synthesis of 4β-sulfonylurea anhydropodophyllotoxin congeners 21a–c.
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Table 1




A549 DU145 KB KBvin
13a >20 >20 >20 >20
13b >20 >20 >20 >20
13c 7.96±0.470 11.94±1.042 10.87±1.280 13.95±0.740
13d 8.25±0.842 8.10±0.410 8.38±0.452 8.76±0.120
13e 7.67 ±0.489 9.66 ± 0.864 9.49 ± 0.821 8.79± 0.585
13f >20 >20 >20 >20
13g 7.72 ± 1.229 9.32 ± 0.337 9.51 ± 0.414 8.35 ± 0.681
13h 7.82±0.424 9.61±0.622 9.00±0.151 7.92±0.863
13i 9.03±0.142 11.52±0.472 10.56±0.256 7.95±0.500
13j 8.63±0.892 11.24±0.824 11.78±0.291 13.99±0.653
13k 8.00 ± 0.383 8.51 ± 0.816 8.08 ± 0.769 8.56 ± 0.818
13l 8.49±0.291 10.53±0.532 9.70±0.294 8.62±0.950
14a >20 >20 >20 >20
14b >20 >20 >20 >20
14c 1.60±0.082 1.44±0.080 1.41±0.112 1.76±0.263
14d >20 >20 >20 >20
14e 1.89±0.162 1.75±0.124 1.72±0.181 2.01±0.323
21a >20 >20 >20 >20
21b 11.79 ± 0.22 11.88 ± 0.152 11.02 ± 0.630 13.17 ± 0.732
21c 14.91± 0.583 14.29 ± 0.108 12.02 ± 0.043 >20
Etoposide 2.58±0.252 2.03±0.121 3.88±0.199 >20
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